Endografts are medical implants used to treat aneurysms – ballooning of the vessel wall due to structural weakness. The endograft is a fabric-covered metallic stent that is inserted into an abdominal aortic aneurysm without need for a surgical approach and its resulting side effects. An endograft comprises one of two types of stented grafts: abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). Abdominal aortic endografts and thoracic aortic endografts are used to relieve pressure on the weakening wall of the ascending or descending aortic vessel. Fenestrated and branched endografts allow for endovascular treatment of aneurysms in close proximity to the renal arteries. Endovascular aortic repair (EVAR) is one of the most significant technological advances in vascular surgery over the last decade and continues to show promise as a less-invasive alternative to conventional surgery in treating patients with abdominal aortic aneurysms or thoracic aortic aneurysms. As the number of endovascular abdominal aortic aneurysm repair procedures continues to grow, particularly in the US, so does the number and variety of devices designed to treat this complicated but potentially deadly condition. The rapid growth of EVAR in both the US and Europe has spawned a sizeable device market for manufacturers operating in this highly specialized space. Over the past 25 years the global market for aortic endografts has increased rapidly, resulting in a wide range of devices from various companies. Currently, there are seven endografts approved by the FDA for the treatment of abdominal aortic aneurysms. These devices offer a wide range of designs intended to increase inclusion criteria while decreasing technical complications such as endoleak and migration.
The global aortic endografts market segmentation is based on device type (abdominal aortic endografts, thoracic aortic endografts, fenestrated and branched aortic endografts, and flow diverting aortic endografts).
The global aortic endografts market research report provides market size (Revenue US$ Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global aortic endografts market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global aortic endografts market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global aortic endografts market and profiled in this report include Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Cordis (Cardinal Health), Endologix, Inc., Endospan, Jotec, Lombard Medical Technologies Plc, Medtronic Plc, Microport Medical, Nano Endoluminal, Terumo Medical Corp., Transcatheter Technologies, TriVascular, Inc., Vascutek, and W. L. Gore and Associates.